# VBIO (VBIO)

> Source: Nexqual · https://nexqual.com/VBIO · data as of 2026-10-15 20:00 UTC · cite as "Nexqual, VBIO (VBIO), nexqual.com/VBIO" · informational, not investment advice.

**Price:** USD 1.23 (-15.17% on the day) · last close of Oct 15, 2026; US market closed, not a live price. Prev close 1.45 · day 1.11–1.3 · 52w 1.11–75.5 · market cap $2.4M · NCM

## Key facts
- Total return with dividends: 1Y -98.3% vs S&P 500 +18.1%; 5Y -100.0% vs S&P 500 +85.1%.

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-16) | 5Y (from 2021-11-08) |
|---|---|---|
| Total return | -98.3% | -100.0% |
| S&P 500 (SPY) | +18.1% | +85.1% |
| Per year | -98.4% | -91.5% |
| Volatility (annualized) | 136.7% | 148.4% |
| Max drawdown | -98.3% (Oct 2025→Oct 2026) | -100.0% (Nov 2021→Oct 2026) |

## Peers
MRAI (Marpai, Inc.) USD 3.19 -0.41% · SPRC (SciSparc Ltd.) USD 2 -49.24% · TNON (Tenon Medical, Inc.) USD 2.91 +0.69% · BJDX (Bluejay Diagnostics, Inc.) USD 0.78 -6.33% · ENSC (Ensysce Biosciences, Inc.) USD 0.6 +4.36%

## More
Full page: https://nexqual.com/VBIO · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt